These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2652605)

  • 1. A critical analysis of serum and urine interleukin 2 receptor assays in renal allograft recipients.
    Colvin RB; Preffer FI; Fuller T; Brown M; Ip S; Kung P; Cosimi AB
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1863. PubMed ID: 2652605
    [No Abstract]   [Full Text] [Related]  

  • 2. Pre-operative interleukin 2 and interleukin 2 receptor levels may predict subsequent renal allograft rejection.
    Cornaby AJ; Simpson MA; Madras PN; Dempsey RA; Clowes GH; Monaco AP
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1861-2. PubMed ID: 2652604
    [No Abstract]   [Full Text] [Related]  

  • 3. Urine sediment cytology in the management of renal allograft recipients.
    Madras PN; Simpson MA; Cornaby AJ; Dempsey RA; Clowes GH; Monaco AP
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1842-3. PubMed ID: 2652599
    [No Abstract]   [Full Text] [Related]  

  • 4. Interleukin-2 receptor positive cell levels in cyclosporin-versus azathioprine-treated renal transplant patients.
    Möhring K; Pomer S; Daniel U; Rambausek M
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1469. PubMed ID: 2652470
    [No Abstract]   [Full Text] [Related]  

  • 5. Interleukin-2 receptor as an immunodiagnostic tool to differentiate rejection from nephrotoxicity.
    Smith AY; Citterio F; Welsh M; Kerman RH; Kahan BD
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1462-4. PubMed ID: 2652467
    [No Abstract]   [Full Text] [Related]  

  • 6. Origin of elevated IL-2 and IL-2R in the urine of rejecting renal allograft recipients.
    Simpson MA; Madras PN; Cornaby AJ; Dempsey RA; Monaco AP
    Transplant Proc; 1989 Feb; 21(1 Pt 1):299-300. PubMed ID: 2650126
    [No Abstract]   [Full Text] [Related]  

  • 7. Soluble interleukin 2 receptor level in liver allograft recipients: an indicator of rejection.
    Perkins JD; Nelson DL; Rakela J; Grambsch PM; Krom RA
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2275-6. PubMed ID: 2540568
    [No Abstract]   [Full Text] [Related]  

  • 8. Usefulness of serum interleukin 2 receptor levels in renal allograft recipients.
    Plaza JJ; Blum G; Ortiz A; Hernando L; Feijoo E; Sanz J; Garcia R; Egido J; Ortiz F
    Transplant Proc; 1992 Feb; 24(1):63-4. PubMed ID: 1539346
    [No Abstract]   [Full Text] [Related]  

  • 9. Monitoring of renal transplant patients with interleukin-2 and interleukin-2 receptor enzyme immunoassay and interleukin-2 receptor immunocytology.
    Dittmer R; Harfmann P; Tenschert W; Arndt R; Busch B
    Transplant Proc; 1990 Oct; 22(5):2284-5. PubMed ID: 2219370
    [No Abstract]   [Full Text] [Related]  

  • 10. Interleukin 2 levels and urine cytology distinguish between cyclosporine toxicity and rejection in renal and liver allograft recipients.
    Cornaby A; Simpson M; Vann Rice R; Dempsey R; Madras P; Jenkins R; Monaco A
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):827-30. PubMed ID: 3291322
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of serum immunological parameters in acute renal allograft rejection.
    Yang J; Li XW; Zheng FL; Bi ZQ
    Transplant Proc; 1996 Jun; 28(3):1443-4. PubMed ID: 8658732
    [No Abstract]   [Full Text] [Related]  

  • 12. Interleukin 2 receptor in rat allograft rejection.
    Bouchot O; Anegon I; Romaniuk A; Jacques Y; Soulillou JP
    Transplant Proc; 1990 Aug; 22(4):1995-7. PubMed ID: 2202134
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum interleukin 2 activity in renal graft recipients.
    Sunder-Plassmann G; Stockenhuber F; Balcke P
    Transplant Proc; 1988 Jun; 20(3):387-9. PubMed ID: 3289167
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum alpha-1 microglobulin levels as indicators of renal function in allograft recipients.
    Duraj F; Bäckman L; Dati F; Ringdén O
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1871-2. PubMed ID: 2469229
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma soluble interleukin-2 receptor (IL-2RS) level and activation markers in blood in the follow-up of renal allograft patients.
    Malcus C; Pouteil-Noble C; Touraine F; Raffaele P; Touraine JL
    Transplant Proc; 1990 Aug; 22(4):1865-6. PubMed ID: 2389463
    [No Abstract]   [Full Text] [Related]  

  • 16. Nonspecific increase of interleukin-2 receptor serum levels during immune events in heart transplantation.
    De Maria R; Zuccelli GC; Masini S; Caroli A; Brando B; Gronda E; Donato L
    Transplant Proc; 1989 Feb; 21(1 Pt 1):440-1. PubMed ID: 2650169
    [No Abstract]   [Full Text] [Related]  

  • 17. Soluble CD23 and interleukin-2 receptor levels in renal allograft recipients.
    Beksaç M; Dalva K; Gönenç F; Dalva I; Gariboğlu S; Batur N; Cetin S
    Transplant Proc; 1993 Apr; 25(2):2145-7. PubMed ID: 8470296
    [No Abstract]   [Full Text] [Related]  

  • 18. Sequential IL-2 and IL-2R levels predict rejection in liver allograft recipients.
    Simpson MA; Young-Fadok T; Madras PN; Freeman RB; Dempsey RA; Jenkins RL; Monaco AP
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1432-3. PubMed ID: 1989255
    [No Abstract]   [Full Text] [Related]  

  • 19. Postoperative endogenous serum cortisol levels as an index of acute rejection and severe infection in renal allograft recipients.
    Kozaki M; Hirano T; Oka K; Honma M; Kang X; Sakurai E; Tamaki T; Tamaki I
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1864-6. PubMed ID: 2652606
    [No Abstract]   [Full Text] [Related]  

  • 20. Soluble interleukin-2 receptor (sIL-2R) and tumor necrosis factor plasma levels in renal allograft recipients.
    Noronha IL; Daniel V; Rambausek M; Waldherr R; Opelz G
    Transplant Proc; 1990 Aug; 22(4):1859-60. PubMed ID: 2117814
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.